Allogeneic hematopoietic cell transplantation for older patients with AML with active disease. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT) (2024) Maffini E, Labopin M, Kröger N, Finke J, Stelljes M, Schroeder T, Einsele H, et al. Journal article Finding a balance in reduced toxicity hematopoietic stem cell transplantation for thalassemia: role of infused CD3+ cell count and immunosuppression (2024) Meissner B, Lang P, Bader P, Hoenig M, Müller I, Meisel R, Greil J, et al. Journal article HLA-mismatched unrelated donor transplantation with post-transplant cyclophosphamide versus HLA-haploidentical transplantation in patients with active acute myeloid leukemia (2022) Baron F, Labopin M, Tischer J, Ciceri F, Raiola AM, Blaise D, Sica S, et al. Conference contribution Impact of IDH1 and IDH2 mutational subgroups in acute myeloid leukemia patients after allogeneic hematopoietic cell transplantation (2022) Kunadt D, Stasik S, Metzeler K, Roellig C, Kramer M, Greif P, Spiekermann K, et al. Conference contribution Patient-reported health-related quality of life (HRQOL) following allogeneic stem cell transplantation (SCT) performed early after diagnosis of pediatric chronic myeloid leukemia (CML) (2022) Schleicher O, Horndasch A, Krumbholz M, Sembill S, Karow A, Bremensdorfer C, Grabow D, et al. Conference contribution Donor genetic determinant of thymopoiesis rs2204985 impacts clinical outcome after single HLA mismatched hematopoietic stem cell transplantation (2022) Tsamadou C, Gowdavally S, Platzbecker U, Sala E, Valerius T, Wagner-Drouet E, Wulf G, et al. Journal article Male-specific late effects in adult hematopoietic cell transplantation recipients: a systematic review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation (2022) Phelan R, Im A, Hunter RL, Inamoto Y, Lupo-Stanghellini MT, Rovo A, Badawy SM, et al. Journal article Augmented FLAMSA-Bu versus FluBu2 reduced-intensity conditioning in patients with active relapsed/refractory acute myeloid leukemia: an EBMT analysis (2022) Rodriguez-Arboli E, Labopin M, Eder M, Brecht A, Blau IW, Huynh A, Forcade E, et al. Journal article Controversies about immunoglobulin replacement therapy in HSCT recipients with hypogammaglobulinemia (2022) Ohmoto A, Fuji S, Shultes KC, Savani BN, Einsele H Journal article, Review article Allogeneic hematopoietic stem cell transplantation for adult HLH: a retrospective study by the chronic malignancies and inborn errors working parties of EBMT (2022) Machowicz R, Suarez F, Wiktor-Jedrzejczak W, Eikema DJ, De Wreede LC, Blok HJ, Isaksson C, et al. Journal article